Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Constellation: BOL-303259-X vs Timolol in Glaucoma
NCT01707381Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Nov 2012
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprostene bunod in open-angle glaucoma (OAG), ocular hypertension, sponsored by Bausch + Lomb. Started Nov 2012; status: completed.
02
Drugs
latanoprostene bunod
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01707381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01707381.